Hankins v. Merck & Company Inc | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Hankins v. Merck & Company Inc

Sort by

Viewing results 1‒25 of 1883

Coronavirus treatment
Merck Covid antiviral pill did not cut hospitalisation risk, study finds
...Merck’s drug, which is branded Lagevrio, raised hopes and sent shares in the company rallying last year after early data from a late-stage trial suggested it cut in half the risk of death and hospitalisation...
October 6, 2022
Merck & Co Inc
Merck to open £1bn London research centre with plea for government support of industry
...Merck’s research chief has called on the UK government to make the country more welcoming to pharma companies, ahead of the US-based drugmaker breaking ground on a £1bn research centre in London next week...
October 15, 2023
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Coronavirus treatment
Covid antivirals lose spark as regulatory scrutiny increases
...The Cypriot government allowed stocks to be used to treat cats suffering with another coronavirus in the Mediterranean country, though the company said it was not approved for veterinary treatment and no...
October 9, 2023
The Week Ahead
Opening arguments begin in Trump trial
...Key economic and company reports Here is a more complete list of what to expect in terms of company reports and economic data this week....
April 21, 2024
Banks
Mike Mayo ❤️ Citi
...But, of course, there’s a reason why it’s widely called Shitibank; the sprawling, gormless Citi has for a v v v very long time proven adept at blithely ambling onto various rakes around the world....
January 2, 2024
Coronavirus treatment
Merck struggles to win European approval for Covid antiviral pill
...Merck’s drug raised fresh hopes and sent shares in the company rallying late last year after early data from a late-stage trial suggested that it cut in half the risk of death and hospitalisation....
February 16, 2022
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
US politics & policy
US targets 10 drugs for pricing negotiations in crackdown on costs
...The new rules give the federal government the power to negotiate lower prices for some of the most expensive prescription drugs produced by Pfizer, Merck and other pharma companies purchased by Medicare,...
August 29, 2023
Merck & Co Inc
Merck accuses US of ‘extortion’ in lawsuit against drug price controls
...Merck’s lawsuit is the first by a major drug company, but analysts predict others are likely to follow its lead and sue the government ahead of the full implementation of the drug price negotiation elements...
June 6, 2023
Coronavirus treatment
Covid antiviral drug linked to ‘transmissible’ mutations, research finds
...Yet Merck recorded sales worth more than $6bn between 2021 and 2022, and the figure does not include sales in poorer markets where licensed companies make generic versions of the drug....
September 25, 2023
LexMerck & Co Inc
Merck/Prometheus: Big Pharma must swallow bigger premiums Premium content
...Yet the company’s monoclonal antibody treatment for inflammatory bowel disease has yet to be fully approved....
April 17, 2023
InterviewBlackRock Inc
How Adebayo Ogunlesi’s contrarian bet led to $12.5bn BlackRock tie-up
...Its companies have combined annual revenues of $75bn and 115,000 employees....
January 14, 2024
Mergers & Acquisitions
Merck buys Prometheus Biosciences for almost $11bn
...Merck said the deal would strengthen the company’s position in the fast-growing field of immunology, where there is significant unmet patient need....
April 16, 2023
HM Revenue & Customs
Walkers’ Sensations Poppadoms vs HMRC: Crunch time
...the crisp company....
January 19, 2024
Coronavirus treatment
Merck antiviral trial shows promising impact on Covid recovery time
...“We are encouraged by these findings from Panoramic,” said Merck, which is known as MSD outside North America....
December 22, 2022
Pharmaceuticals sector
Big Pharma fights patent disclosure demand from investors
...Implementing the proposals could undermine the company’s core business model, said Merck in response to a proposal made by The Capuchin Franciscan Province of St. Joseph....
February 26, 2023
FT Live
Due Diligence Live
Where leaders in investment and finance meet
Tuesday, 8 OctoberLondon, UK
LexPfizer Inc
Pfizer/Seagen: post-Covid growth does not come cheaply Premium content
...Merck was in talks last summer to acquire Seagen for about $200 a share, or $40bn. But negotiations ended after the two failed to agree on price....
March 13, 2023
Drugs research
Moderna’s mRNA cancer vaccine shows promise in early trial
...Dean Li, president of Merck Research Laboratories, said the positive trial findings represented an important milestone in the company’s collaboration with Moderna....
December 13, 2022
Pfizer Inc
Pfizer to buy oncology-focused biotech Seagen for $43bn
...Merck had been in talks to acquire Seagen last summer, offering about $200 a share, according to people familiar with the matter....
March 13, 2023
LexElaine Moore
The Lex Newsletter: a Spac clapback Premium content
...Campaigners are supported by more than 400 senior pharma and biotech executives at companies, including Pfizer and Merck, who have spoken out against a preliminary injunction against abortion pill mifepristone...
April 14, 2023
LexDrugs research
Medicines: triumph of science in 2022 is worth celebrating Premium content
...Merck’s Keytruda now tackles 18 tumour types and is set to be the world’s top-selling medicine next year, according to Evaluate Vantage....
December 23, 2022
AbbVie Inc
Blockbuster AbbVie drug Humira to face competition in US for first time
...Merck, Bristol Myers Squibb and Amgen have all used these aggressive tactics to protect blockbuster drugs from competition, said O’Reilly....
January 31, 2023
Pharmaceuticals sector
Merck defends tax approach against senator’s claims of avoidance
...Drugmaker Merck has defended the company’s approach to tax after a US congressional committee accused it of exploiting loopholes to avoid paying billions of dollars and blocking an inquiry into its practices...
August 7, 2022
LexMerck & Co Inc
Merck/SeaGen: regulatory hurdles will be tough to clear Premium content
...On paper, Merck’s interest in buying the cancer biotechnology company SeaGen for about $40bn makes plenty of sense. The US drugmaker is flush with cash — to the tune of $8.6bn at the end of March....
July 8, 2022
Pfizer Inc
Pfizer pins hopes on record pipeline to recover from post-Covid hangover
...“Pfizer is very good at selling but historically not renowned as having the R&D engine of a Merck or Lilly....
February 21, 2023
ETF Hub
Volatile markets increase appeal of ETFs with a buffer
...I think a lot of people were anticipating a V-shaped recovery . . . People are now waking up the realisation that volatility is going to be normal going forward.”...
April 24, 2023

Previous pagePage 1 of 76Next page